DZ Bank Call 18 IVU 21.06.2024/ DE000DJ3MZY1 /
| 2024-05-14 1:35:12 PM | Chg.+0.040 | Bid2024-05-14 | Ask2024-05-14 | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 0.110EUR | +57.14% | 0.110 Bid Size: 4,000 |
0.160 Ask Size: 4,000 |
IVU TRAFFIC TECHN.AG... | 18.00 - | 2024-06-21 | Call |
GlobeNewswire
1:57 PM
ZyVersa Therapeutics' CEO, Stephen C. Glover, to Participate in the 2024 BIO International Conventio...
GlobeNewswire
1:55 PM
IO Biotech Reports First Quarter 2024 Financial Results and Provides Business Highlights
GlobeNewswire
1:45 PM
Global Technologies, Ltd. Announces Its Financial Results for the Quarter Ended March 31, 2024 and t...
Newsfile Corp
1:44 PM
Appia Announces Encouraging Initial Results from the Newly Identified Taygeta and Merope Exploration...
GlobeNewswire
1:30 PM
Pyxis Oncology Provides Corporate Update and Reports Financial Results for First Quarter 2024
GlobeNewswire
1:30 PM
Profound Medical Receives U.S. FDA 510(k) Clearance for ‘Contouring Assistant’ AI Module that Enable...
GlobeNewswire
1:30 PM
ETFS Capital Calls on WisdomTree to Stop Fighting Stockholders and Run a Strategic Process
GlobeNewswire
1:30 PM
Pliant Therapeutics Announces Positive Topline Data from a Phase 2a Collagen PET Imaging Clinical Tr...
GlobeNewswire
1:30 PM
Vivos Therapeutics Schedules Release of First Quarter 2024 Financial Results and Conference Call
GlobeNewswire
1:30 PM
Kura Oncology Completes Enrollment in Registration-Directed Trial of Ziftomenib in NPM1-Mutant AML
GlobeNewswire
1:30 PM
Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
GlobeNewswire
1:30 PM
BridgeBio Pharma to Participate in the Bank of America Merrill Lynch Global Healthcare Conference 20...
GlobeNewswire
1:30 PM
XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ
